age
float64 18
102
| sex
stringclasses 2
values | hospdead
int64 0
1
| slos
int64 3
343
| dzgroup
stringclasses 8
values | dzclass
stringclasses 4
values | num.co
int64 0
9
| edu
float64 0
31
⌀ | income
stringclasses 4
values | scoma
float64 0
100
⌀ | charges
float64 1.17k
1.44M
⌀ | totcst
float64 0
633k
⌀ | totmcst
float64 -102.72
711k
⌀ | avtisst
float64 1
83
⌀ | race
stringclasses 5
values | sps
float64 0.2
99.2
⌀ | aps
float64 0
143
⌀ | surv2m
float64 0
0.97
⌀ | surv6m
float64 0
0.95
⌀ | hday
int64 1
148
| diabetes
int64 0
1
| dementia
int64 0
1
| ca
stringclasses 3
values | prg2m
float64 0
1
⌀ | prg6m
float64 0
1
⌀ | dnr
stringclasses 3
values | dnrday
float64 -88
285
⌀ | meanbp
float64 0
195
⌀ | wblc
float64 0
200
⌀ | hrt
float64 0
300
⌀ | resp
float64 0
90
⌀ | temp
float64 31.7
41.7
⌀ | pafi
float64 12
890
⌀ | alb
float64 0.4
29
⌀ | bili
float64 0.1
63
⌀ | crea
float64 0.1
21.5
⌀ | sod
float64 110
181
⌀ | ph
float64 6.83
7.77
⌀ | glucose
float64 0
1.09k
⌀ | bun
float64 1
300
⌀ | urine
float64 0
9k
⌀ | adlp
float64 0
7
⌀ | adls
float64 0
7
⌀ | sfdm2
stringclasses 5
values | adlsc
float64 0
7.07
| event_times
int64 3
2.03k
| event_indicators
int64 0
1
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
66.53796
|
male
| 0
| 33
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| null | null | 0
| 15,308.594
| 13,682.9844
| null | 8.25
|
white
| 28.296875
| 46
| 0.73999
| 0.590942
| 1
| 0
| 0
|
no
| 0.95
| 0.5
|
no dnr
| 33
| 59
| 8.5
| 54
| 20
| 35.29688
| null | null | null | 2.899902
| 131
| null | null | null | null | null | null |
<2 mo. follow-up
| 3.023926
| 43
| 1
|
52.392
|
male
| 0
| 4
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 11
|
under $11k
| 0
| 2,009.25
| 1,732.7705
| null | 5
|
black
| 25.796875
| 30
| 0.834961
| 0.72998
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 4
| 110
| 6.299805
| 70
| 18
| 36
| 404.75
| 2.899902
| 1.099854
| 4.699219
| 140
| 7.479492
| null | null | null | 0
| null |
no(M2 and SIP pres)
| 0.4948
| 1,638
| 1
|
70.14899
|
male
| 0
| 77
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 8
| null | 9
| 85,999.312
| 64,279.6875
| null | 22.5
|
white
| 19.097656
| 20
| 0.601929
| 0.494995
| 20
| 0
| 0
|
metastatic
| 0.5
| 0.3
|
dnr after sadm
| 1
| 94
| 6.299805
| 112
| 16
| 37.09375
| 226.90625
| 2.5
| 1.5
| 0.899902
| 139
| 7.40918
| null | null | null | null | 4
|
SIP>=30
| 4
| 88
| 1
|
61.64297
|
male
| 0
| 28
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| null | null | 9
| 69,951.25
| 47,864.1562
| null | 26
|
white
| 24
| 19
| 0.756958
| 0.679932
| 5
| 0
| 0
|
no
| 0.2
| 0.1
|
dnr after sadm
| 11
| 111
| 1.199951
| 82
| 11
| 37.69531
| 226.65625
| null | 1.299805
| 0.799927
| 131
| 7.429688
| null | null | null | null | null | null | 2.285645
| 78
| 1
|
65.396
|
male
| 1
| 15
|
Coma
|
Coma
| 1
| null | null | 100
| 26,288.375
| 18,995.1875
| null | 19.333328
|
black
| 27.898438
| 46
| 0.112991
| 0.069992
| 1
| 0
| 0
|
no
| 0
| 0
|
dnr after sadm
| 4
| 80
| 30.296875
| 130
| 32
| 37.89844
| 240
| 2.799805
| null | 2.199707
| 133
| 7.419922
| null | null | null | null | null |
<2 mo. follow-up
| 2.63916
| 15
| 1
|
64.17499
|
female
| 0
| 3
|
Lung Cancer
|
Cancer
| 1
| 8
|
under $11k
| 0
| 2,555.35
| 1,988.8213
| null | 5
|
black
| 16.699219
| 16
| 0.715942
| 0.436951
| 1
| 0
| 0
|
metastatic
| 0.5
| 0.2
|
no dnr
| 3
| 79
| 10.199219
| 100
| 20
| 36.79688
| null | null | 0.199982
| 0.799927
| 137
| null | null | null | null | 1
| 3
|
adl>=4 (>=5 if sur)
| 3
| 71
| 1
|
77.77399
|
male
| 0
| 25
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| null | null | 0
| null | null | null | 20
|
white
| 15.298828
| 12
| 0.825928
| 0.767944
| 19
| 0
| 0
|
no
| null | null |
no dnr
| 25
| 106
| 11.298828
| 68
| 11
| 38.59375
| 350
| null | 1.399902
| 1
| 138
| 7.5
| null | null | null | null | null | null | 1.827393
| 1,988
| 0
|
64.70398
|
female
| 1
| 35
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 8
|
under $11k
| 9
| 146,233.75
| 97,332.125
| null | 44.25
|
white
| 25.597656
| 12
| 0.690918
| 0.598999
| 11
| 0
| 0
|
no
| 0.2
| 0.2
|
dnr after sadm
| 34
| 87
| 15.898438
| 94
| 14
| 37.5
| 165
| null | null | 0.599976
| 129
| 7.459961
| null | null | null | null | 5
|
<2 mo. follow-up
| 5
| 35
| 1
|
51.362
|
male
| 1
| 5
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| null | null | 44
| 18,635
| 13,307.5312
| null | 55
|
black
| 17.398438
| 15
| 0.834961
| 0.778931
| 1
| 0
| 0
|
no
| 0.1
| 0.001
|
no dnr
| 5
| 117
| 8.599609
| 110
| 11
| 38.69531
| 400
| null | null | 0.699951
| 140
| 7.509766
| null | null | null | null | null |
<2 mo. follow-up
| 2.084473
| 5
| 1
|
78.66699
|
female
| 0
| 12
|
Lung Cancer
|
Cancer
| 4
| 8
|
under $11k
| 0
| 10,843.562
| 7,996.9375
| null | 9
|
white
| 19.5
| 28
| 0.615967
| 0.301941
| 1
| 0
| 0
|
metastatic
| 0.7
| 0.5
|
no dnr
| 12
| 93
| 4.699219
| 112
| 20
| 37
| 233.3125
| null | null | 0.599976
| 141
| 7.429688
| null | null | null | 3
| 7
|
adl>=4 (>=5 if sur)
| 7
| 334
| 1
|
65.53595
|
male
| 0
| 7
|
Lung Cancer
|
Cancer
| 1
| null | null | 0
| 5,538.25
| 4,378.1055
| null | 3
|
white
| 21.199219
| 11
| 0.613892
| 0.29895
| 1
| 0
| 0
|
metastatic
| 0.5
| 0.2
|
no dnr
| 7
| 93
| 9.798828
| 86
| 20
| 38.69531
| 342.8125
| 2.799805
| 0.299988
| 0.799927
| 138
| 7.489258
| null | null | null | null | null | null | 2.887695
| 88
| 1
|
62.37399
|
female
| 0
| 17
|
Colon Cancer
|
Cancer
| 1
| null | null | 0
| 23,129.641
| 15,278.625
| null | 9
|
white
| 17.597656
| 11
| 0.813965
| 0.599976
| 1
| 0
| 0
|
metastatic
| 0.9
| 0.5
|
no dnr
| 17
| 70
| 8
| 68
| 20
| 37.19531
| null | 3.199707
| 1
| 0.799927
| 140
| null | null | null | null | null | null | null | 2.299316
| 211
| 1
|
54.168
|
male
| 0
| 5
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 4
| 8
|
under $11k
| 9
| 9,294.195
| 6,839.5078
| null | 22
|
white
| 26.5
| 39
| 0.784912
| 0.714966
| 1
| 1
| 0
|
no
| null | null |
no dnr
| 5
| 87
| 15.599609
| 90
| 26
| 35
| 336.625
| null | null | 9.099609
| 135
| 7.419922
| null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 174
| 1
|
74.84198
|
female
| 1
| 18
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 8
|
under $11k
| 0
| 72,912.25
| 47,838.625
| null | 42.333313
|
white
| 28.296875
| 52
| 0.692993
| 0.600952
| 1
| 0
| 0
|
no
| 0.7
| 0.5
|
dnr after sadm
| 11
| 85
| 14.199219
| 60
| 26
| 36.59375
| 157.5
| 1.699951
| 0.899902
| 2.899902
| 138
| 7.439453
| null | null | null | null | 7
|
<2 mo. follow-up
| 7
| 18
| 1
|
52.047
|
male
| 1
| 6
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| null | null | 0
| 4,845.676
| 3,496.2949
| null | 11
|
white
| 23.097656
| 22
| 0.866943
| 0.778931
| 1
| 0
| 0
|
no
| 0.25
| 0
|
no dnr
| 6
| 88
| null | 100
| 32
| 35.29688
| 197.5
| 3.699707
| 1.699951
| 1
| 133
| 7.449219
| null | null | null | null | null |
<2 mo. follow-up
| 2.243164
| 6
| 1
|
57.34198
|
male
| 0
| 6
|
Colon Cancer
|
Cancer
| 2
| 12
|
$25-$50k
| 0
| 5,654.199
| 3,763.8496
| null | 15
|
white
| 12.599609
| 22
| 0.87793
| 0.724976
| 1
| 1
| 0
|
metastatic
| 0.9
| 0.8
|
no dnr
| 6
| 129
| 2.899902
| 95
| 20
| 36.5
| null | 3.699707
| 0.399963
| 1.099854
| 139
| null | null | null | null | 1
| 0
|
no(M2 and SIP pres)
| 0
| 1,116
| 1
|
67.92096
|
male
| 0
| 20
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 11
|
$11-$25k
| 0
| 23,931.641
| 17,996.2188
| null | 11
|
white
| 14
| 19
| 0.879883
| 0.799927
| 9
| 1
| 0
|
no
| 0.75
| 0.5
|
no dnr
| 20
| 83
| null | 72
| 22
| 37
| null | null | null | 1.299805
| 139
| null | null | null | null | 2
| 7
|
no(M2 and SIP pres)
| 7
| 113
| 1
|
60.17499
|
female
| 0
| 10
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 14
|
$11-$25k
| 0
| 26,265.516
| 18,830.0469
| null | 23.5
|
white
| 16.597656
| 18
| 0.86792
| 0.821899
| 10
| 0
| 0
|
no
| null | null |
no dnr
| 10
| 100
| 7.299805
| 82
| 24
| 37.09375
| 190
| null | null | 1.099854
| 133
| 7.479492
| null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,985
| 0
|
75.06097
|
male
| 0
| 15
|
CHF
|
COPD/CHF/Cirrhosis
| 4
| 12
| null | 0
| 36,334.688
| 23,794.0312
| null | 24
|
black
| 17.898438
| 28
| 0.843994
| 0.744995
| 2
| 0
| 0
|
no
| 0.8
| 0.75
|
no dnr
| 15
| 84
| 8.699219
| 100
| 32
| 36.5
| 264
| null | null | 1.199951
| 140
| 7.469727
| null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 651
| 1
|
66.04797
|
male
| 0
| 37
|
Lung Cancer
|
Cancer
| 1
| 6
|
under $11k
| 0
| 31,104.797
| 24,269.2812
| null | 6.25
|
black
| 19.898438
| 33
| 0.643921
| 0.336975
| 1
| 0
| 0
|
metastatic
| 0.5
| 0.1
|
no dnr
| 37
| 107
| 7
| 100
| 0
| 37
| 276.1875
| null | null | 0.899902
| 138
| 7.569336
| null | null | null | 1
| 2
| null | 2
| 63
| 1
|
29.37399
|
male
| 0
| 38
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 13
|
$11-$25k
| 0
| 83,731.188
| 58,268.3125
| null | 31.75
|
white
| 31.699219
| 64
| 0.817993
| 0.756958
| 1
| 0
| 0
|
no
| 0.4
| 0.4
|
no dnr
| 38
| 127
| 26.699219
| 115
| 30
| 37.5
| 122
| 1.799805
| 0.5
| 7.399414
| 139
| 7.449219
| null | null | null | null | 0
| null | 0
| 1,984
| 0
|
76.31195
|
male
| 1
| 51
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
|
>$50k
| 37
| 167,402.25
| 115,299.625
| null | 40.25
|
white
| 22.796875
| 51
| 0.661987
| 0.564941
| 1
| 1
| 0
|
no
| 0.7
| 0.6
|
dnr after sadm
| 48
| 65
| 23
| 80
| 8
| 35.69531
| 192.5
| null | 0.199982
| 11
| 135
| 7.339844
| null | null | null | null | 1
|
<2 mo. follow-up
| 1
| 51
| 1
|
64.92798
|
female
| 0
| 27
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 13
| null | 0
| 28,759.891
| 20,046.1562
| null | 11.75
|
white
| 22.097656
| 26
| 0.841919
| 0.741943
| 1
| 0
| 0
|
no
| 0.5
| 0.4
|
dnr after sadm
| 5
| 85
| 7.699219
| 192
| 20
| 36.69531
| 247.8125
| null | null | 0.5
| 137
| 7.329102
| null | null | null | null | 1
|
<2 mo. follow-up
| 1
| 46
| 1
|
40.24597
|
male
| 0
| 14
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
|
$25-$50k
| 9
| 46,602.594
| 32,411.6406
| null | 17.666656
|
white
| 19.5
| 13
| 0.876953
| 0.833984
| 6
| 0
| 0
|
no
| 0.8
| 0.8
|
no dnr
| 14
| 117
| 11.699219
| 92
| 26
| 37.79688
| 352
| null | 0.899902
| 0.599976
| 135
| 7.459961
| null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,982
| 0
|
37.21597
|
female
| 0
| 6
|
CHF
|
COPD/CHF/Cirrhosis
| 1
| 10
| null | 0
| 3,067.549
| 2,543.8203
| null | 6
|
black
| 21.5
| 26
| 0.912964
| 0.853882
| 1
| 0
| 0
|
no
| 0.9
| 0.75
|
no dnr
| 6
| 79
| 9.398438
| 68
| 28
| 36.29688
| 552.375
| 3.199707
| 1.099854
| 1.799805
| 137
| 7.419922
| null | null | null | 2
| null |
<2 mo. follow-up
| 1.839
| 10
| 1
|
36.91199
|
male
| 0
| 4
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 9
|
under $11k
| 0
| 7,022.199
| 4,800.3203
| null | 12
|
black
| 18.097656
| 4
| 0.93396
| 0.886963
| 1
| 0
| 0
|
no
| 0.8
| 0.6
|
no dnr
| 4
| 84
| 5.299805
| 54
| 22
| 35.79688
| null | null | null | 1
| 138
| null | null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,980
| 0
|
64.87598
|
female
| 0
| 10
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 16
|
$11-$25k
| 0
| 38,151.344
| 24,751.4375
| null | 22
|
white
| 26.398438
| 26
| 0.491943
| 0.373962
| 7
| 0
| 0
|
metastatic
| null | null |
no dnr
| 10
| 131
| 16
| 68
| 26
| 35
| 155
| null | null | 1.199951
| 136
| 7.229492
| null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 993
| 1
|
61.68698
|
female
| 1
| 6
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 12
|
under $11k
| 0
| 68,088.938
| 45,102.3438
| null | 35
|
black
| 37.398438
| 79
| 0.450989
| 0.33197
| 11
| 1
| 0
|
no
| 0.7
| 0.7
|
dnr after sadm
| 2
| 67
| 11.298828
| 110
| 40
| 36.69531
| 160
| 2.899902
| 19.097656
| 1.5
| 148
| 7.509766
| null | null | null | null | 7
|
<2 mo. follow-up
| 7
| 6
| 1
|
60.91397
|
male
| 1
| 4
|
Coma
|
Coma
| 1
| null | null | 100
| 20,829.844
| 13,774.2266
| null | 28
|
white
| 21.5
| 30
| 0.120987
| 0.075989
| 3
| 0
| 0
|
metastatic
| 0.1
| 0.001
|
dnr after sadm
| 2
| 73
| 21.699219
| 98
| 18
| 38.89844
| 383
| null | 0.699951
| 2.199707
| 136
| 7.269531
| null | null | null | null | null |
<2 mo. follow-up
| 2.95459
| 4
| 1
|
72.09296
|
male
| 0
| 3
|
Lung Cancer
|
Cancer
| 1
| null | null | 0
| 2,642.119
| 2,043.2197
| null | 3
|
white
| 22.5
| 11
| 0.559937
| 0.237976
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 3
| 93
| 11.298828
| 96
| 20
| 37.09375
| null | 2.899902
| 0.299988
| 1
| 136
| null | null | null | null | null | null |
<2 mo. follow-up
| 2.222656
| 53
| 1
|
51.28
|
male
| 0
| 7
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 3
| null | null | 0
| 5,919.547
| 4,320.3984
| null | 9.5
|
white
| 31.296875
| 49
| 0.635986
| 0.453979
| 1
| 0
| 0
|
no
| 0.4
| 0.1
|
dnr after sadm
| 2
| 67
| 6.799805
| 118
| 36
| 36.59375
| 309.5
| 2.5
| null | 5.599609
| 127
| 7.449219
| null | null | null | null | null |
<2 mo. follow-up
| 3.286621
| 8
| 1
|
49.87799
|
female
| 0
| 6
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 15
|
under $11k
| 0
| 9,162.547
| 6,519.2109
| null | 13
|
black
| 17.898438
| 23
| 0.907959
| 0.873901
| 1
| 0
| 0
|
no
| 0.8
| 0.75
|
no dnr
| 6
| 90
| 6.699219
| 68
| 10
| 36.19531
| 271.375
| null | 1.099854
| 1
| 142
| 7.269531
| null | null | null | 7
| 7
|
adl>=4 (>=5 if sur)
| 7
| 1,977
| 0
|
76.71198
|
male
| 0
| 46
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 9
|
>$50k
| 0
| 41,699.688
| 33,209.4062
| null | 13.75
|
white
| 24.699219
| 34
| 0.75293
| 0.674927
| 1
| 0
| 0
|
no
| 0.7
| 0.6
|
no dnr
| 46
| 109
| 5
| 115
| 29
| 35.59375
| 228
| 2.699707
| 0.799927
| 1
| 142
| 7.479492
| null | null | null | null | 7
|
adl>=4 (>=5 if sur)
| 7
| 1,895
| 1
|
63.392
|
male
| 1
| 10
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 18
|
$25-$50k
| 9
| 39,656.938
| 27,532.3125
| null | 37
|
white
| 32.09375
| 50
| 0.634888
| 0.532959
| 1
| 0
| 0
|
no
| 0.4
| 0.3
|
dnr after sadm
| 9
| 67
| 14.199219
| 130
| 20
| 37.09375
| 180
| 2.299805
| 0.299988
| 5.299805
| 130
| 7.369141
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 10
| 1
|
68.99396
|
female
| 1
| 5
|
Coma
|
Coma
| 4
| null | null | 100
| 17,598.688
| 11,907.1094
| null | 30
|
white
| 31.5
| 47
| 0.038994
| 0.018997
| 1
| 1
| 0
|
no
| 0.05
| 0.000125
|
dnr after sadm
| 2
| 53
| 12.798828
| 114
| 10
| 39.29688
| 323.3125
| null | 0.099991
| 4.099609
| 151
| 7.55957
| null | null | null | null | null |
<2 mo. follow-up
| 3.381836
| 5
| 1
|
61.84497
|
female
| 0
| 13
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 12
|
$11-$25k
| 0
| 11,096.047
| 8,529.4297
| null | 18
|
white
| 20.898438
| 8
| 0.861938
| 0.770996
| 1
| 0
| 0
|
no
| 0.7
| 0.5
|
no dnr
| 13
| 83
| 9.5
| 88
| 20
| 36
| null | null | 0.5
| 1
| 126
| null | null | null | null | 3
| 6
|
<2 mo. follow-up
| 6
| 50
| 1
|
76.90094
|
female
| 1
| 11
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 14
| null | 41
| null | null | null | 38
|
white
| 26.898438
| 43
| 0.541992
| 0.427979
| 1
| 0
| 0
|
no
| 0.4
| 0.25
|
dnr after sadm
| 5
| 130
| 11.099609
| 85
| 26
| 37.89844
| 130
| 1.699951
| 2.199707
| 0.799927
| 129
| 7.419922
| null | null | null | null | 7
|
<2 mo. follow-up
| 7
| 11
| 1
|
51.63898
|
male
| 0
| 25
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 12
|
$11-$25k
| 0
| 77,591.312
| 52,269.4375
| null | 24.75
|
white
| 26.898438
| 34
| 0.812988
| 0.695923
| 8
| 0
| 0
|
no
| 0.5
| 0.3
|
no dnr
| 25
| 132
| 10.898438
| 138
| 11
| 37.79688
| 202.5
| null | null | 2.199707
| 151
| 7.40918
| null | null | null | null | 0
| null | 0
| 1,975
| 0
|
53.85898
|
male
| 0
| 9
|
CHF
|
COPD/CHF/Cirrhosis
| 4
| 8
|
$11-$25k
| 0
| 7,230.598
| 5,601.1641
| null | 8.5
|
white
| 16.796875
| 11
| 0.91394
| 0.85498
| 1
| 0
| 0
|
no
| 0.8
| 0.7
|
no dnr
| 9
| 90
| 12.099609
| 76
| 20
| 36
| null | null | 0.799927
| 1.299805
| 138
| null | null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,973
| 0
|
48.08798
|
female
| 0
| 19
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null | null | 26
| 97,578.812
| 64,881.625
| null | 32.333313
|
white
| 21.796875
| 14
| 0.774902
| 0.701904
| 13
| 0
| 0
|
no
| null | null |
no dnr
| 19
| 83
| 11.199219
| 110
| 26
| 39.09375
| 328.5625
| null | null | 0.799927
| 145
| 7.389648
| null | null | null | null | null | null | 2.790039
| 1,973
| 0
|
63.07498
|
male
| 0
| 9
|
CHF
|
COPD/CHF/Cirrhosis
| 1
| null | null | 0
| 15,978.344
| 12,662.4219
| null | 17
|
white
| 20.398438
| 27
| 0.863892
| 0.773926
| 1
| 0
| 0
|
no
| 0.7
| 0.6
|
no dnr
| 9
| 73
| 8
| 112
| 20
| 36.79688
| null | null | null | 1.599854
| 135
| null | null | null | null | null | null | null | 2.358887
| 148
| 1
|
31.16499
|
female
| 1
| 26
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 14
|
$25-$50k
| 37
| 94,713.188
| 61,565.8125
| null | 36.5
|
white
| 22.597656
| 24
| 0.759888
| 0.68396
| 7
| 0
| 0
|
yes
| 0.15
| 0.15
|
dnr after sadm
| 9
| 95
| 4.899414
| 84
| 14
| 36.69531
| 164
| null | null | 1.599854
| 141
| 7.529297
| null | null | null | null | 7
|
<2 mo. follow-up
| 7
| 26
| 1
|
46.22598
|
male
| 0
| 223
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 9
| null | 0
| 379,459.75
| 259,995.125
| null | 31
|
black
| 22.699219
| 18
| 0.836914
| 0.781982
| 10
| 0
| 0
|
no
| 0.1
| 0.001
|
no dnr
| 223
| 73
| 22.796875
| 70
| 18
| 38.89844
| 134
| null | null | 0.799927
| 147
| 7.419922
| null | null | null | null | 1
|
adl>=4 (>=5 if sur)
| 1
| 1,971
| 0
|
50.754
|
male
| 0
| 38
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 1
| 15
|
$25-$50k
| 0
| null | null | null | 34.25
|
white
| 18.796875
| 28
| 0.850952
| 0.754883
| 1
| 0
| 0
|
no
| 0.5
| 0.3
|
no dnr
| 38
| 107
| 9.699219
| 95
| 12
| 38.89844
| 200
| 1.199951
| 4.199219
| 1.099854
| 140
| 7.479492
| null | null | null | null | 0
| null | 0
| 63
| 1
|
68
|
female
| 0
| 16
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 8
|
under $11k
| 0
| 28,079.641
| 17,201.5625
| null | 22
|
white
| 25.597656
| 28
| 0.709961
| 0.549927
| 13
| 0
| 0
|
no
| 0.7
| 0.4
|
no dnr
| 16
| 93
| 3.699707
| 105
| 24
| 37.19531
| 280
| null | 0.599976
| 4.699219
| 130
| 7.439453
| null | null | null | 2
| 5
|
no(M2 and SIP pres)
| 5
| 1,382
| 1
|
75.40594
|
male
| 0
| 39
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null | null | 9
| 113,901.062
| 67,952.9375
| null | 22.75
|
black
| 30.699219
| 56
| 0.380981
| 0.261963
| 49
| 0
| 0
|
yes
| 0.5
| 0.5
|
no dnr
| 39
| 110
| 25
| 114
| 35
| 37.29688
| 202.5
| 2
| 5.399414
| 1.599854
| 150
| 7.429688
| null | null | null | null | null | null | 3.052734
| 1,971
| 0
|
54.15997
|
female
| 0
| 4
|
Lung Cancer
|
Cancer
| 1
| 12
|
>$50k
| 0
| 3,714.449
| 2,417.3125
| null | 11
|
white
| 14.798828
| 9
| 0.771973
| 0.525879
| 1
| 0
| 0
|
metastatic
| 0.9
| 0.5
|
no dnr
| 4
| 87
| 4.599609
| 64
| 24
| 37
| null | null | 0.199982
| 0.699951
| 139
| null | null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 524
| 1
|
55.36499
|
male
| 0
| 4
|
Lung Cancer
|
Cancer
| 1
| 12
|
$11-$25k
| 0
| 3,038.5
| 2,171.8731
| null | 11
|
white
| 13.699219
| 12
| 0.785889
| 0.550903
| 1
| 0
| 0
|
metastatic
| null | 0.6
|
no dnr
| 4
| 73
| 7.899414
| 86
| 20
| 37.09375
| 476.1875
| null | null | 1.199951
| 141
| 7.459961
| null | null | null | 0
| 2
|
no(M2 and SIP pres)
| 2
| 831
| 1
|
43.20599
|
male
| 1
| 16
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 4
| 6
| null | 61
| 49,218.781
| 33,914.5938
| null | 33
|
black
| 37.695313
| 67
| 0.358948
| 0.240997
| 1
| 0
| 0
|
no
| 0.15
| 0.5
|
dnr after sadm
| 8
| 60
| 9.5
| 130
| 34
| 37.29688
| 120
| 2
| 16.796875
| 1.799805
| 143
| 7.419922
| null | null | null | null | 2
|
<2 mo. follow-up
| 2
| 16
| 1
|
31.088
|
male
| 0
| 42
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 6
|
$25-$50k
| 37
| 68,183.562
| 50,421.75
| null | 18
|
black
| 20
| 5
| 0.862915
| 0.815918
| 2
| 0
| 0
|
no
| null | null |
no dnr
| 42
| 89
| 12.699219
| 84
| 15
| 35.19531
| 383.3125
| null | null | 0.799927
| 139
| 7.369141
| null | null | null | null | null |
adl>=4 (>=5 if sur)
| 2.641602
| 1,969
| 0
|
59.28
|
female
| 1
| 6
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 12
|
under $11k
| 44
| 17,659.438
| 12,042.7422
| null | 18
|
black
| 32.796875
| 50
| 0.391968
| 0.272949
| 7
| 0
| 0
|
no
| 0.1
| 0.001
|
dnr after sadm
| 1
| 79
| 21.5
| 130
| 22
| 37.19531
| 100
| null | 0.599976
| 1.5
| 130
| 7.389648
| null | null | null | null | 6
|
<2 mo. follow-up
| 6
| 6
| 1
|
60.67398
|
male
| 1
| 15
|
MOSF w/Malig
|
ARF/MOSF
| 1
| null | null | 0
| null | null | null | 47
|
white
| 32.5
| 31
| 0.497986
| 0.379944
| 1
| 0
| 0
|
yes
| 0.2
| 0.3
|
dnr after sadm
| 15
| 96
| 5.599609
| 125
| 24
| 35.09375
| 89.40625
| null | 0.299988
| 1
| 138
| 7.509766
| null | null | null | null | null |
<2 mo. follow-up
| 2.536133
| 15
| 1
|
39.633
|
female
| 0
| 37
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
|
under $11k
| 0
| 140,303.625
| 92,924.625
| null | 35.75
|
white
| 26.199219
| 44
| 0.816895
| 0.754883
| 8
| 0
| 0
|
no
| 0.75
| 0.75
|
no dnr
| 37
| 105
| 27.699219
| 114
| 37
| 38.5
| 296.625
| 1.799805
| 2.599609
| 0.599976
| 132
| 7.449219
| null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 1,967
| 0
|
59.87399
|
female
| 0
| 60
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 16
|
$11-$25k
| 41
| 149,420.5
| 101,527.875
| null | 44.75
|
white
| 30.898438
| 41
| 0.543945
| 0.429993
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 60
| 67
| 9.699219
| 118
| 36
| 39.5
| 106.65625
| 2.5
| 0.899902
| 0.599976
| 135
| 7.479492
| null | null | null | null | 0
|
SIP>=30
| 0
| 298
| 1
|
47.97498
|
male
| 0
| 15
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 12
|
$25-$50k
| 0
| 34,673.594
| 20,768.1875
| null | 14.333328
|
black
| 16.898438
| 20
| 0.92395
| 0.870972
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 15
| 89
| 6.399414
| 62
| 16
| 36.39844
| null | null | 0.299988
| 1.5
| 135
| null | null | null | null | 1
| 0
|
no(M2 and SIP pres)
| 0
| 423
| 1
|
60.03598
|
male
| 1
| 6
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
|
under $11k
| 0
| 47,314.344
| 30,738.2656
| null | 49
|
white
| 23.296875
| 35
| 0.810913
| 0.748901
| 3
| 0
| 0
|
no
| 0.2
| 0.1
|
dnr after sadm
| 5
| 67
| 3.099609
| 75
| 26
| 38
| 353.3125
| null | 1.199951
| 2
| 136
| 7.449219
| null | null | null | null | 1
|
<2 mo. follow-up
| 1
| 6
| 1
|
73.57697
|
female
| 1
| 34
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 6
|
under $11k
| 44
| 89,045.438
| 61,724.125
| null | 31.75
|
black
| 23.597656
| 37
| 0.608887
| 0.501953
| 2
| 1
| 0
|
no
| 0.1
| 0.001
|
dnr after sadm
| 12
| 111
| 15.898438
| 116
| 41
| 38.5
| 350
| 2.799805
| 1.099854
| 1.599854
| 141
| 7.459961
| null | null | null | null | 2
|
<2 mo. follow-up
| 2
| 34
| 1
|
86.41199
|
male
| 1
| 4
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| null | null | 61
| 18,622.797
| 12,580.5469
| null | 47
|
white
| 46.796875
| 61
| 0.006
| 0
| 1
| 0
| 0
|
no
| null | null |
dnr after sadm
| 2
| 43
| 12.5
| 40
| 40
| 37.09375
| 104.07812
| null | null | 3.299805
| 143
| 7.40918
| null | null | null | null | null |
<2 mo. follow-up
| 3.708984
| 4
| 1
|
32.97498
|
male
| 1
| 20
|
Coma
|
Coma
| 0
| 14
|
$11-$25k
| 100
| 74,168.5
| 50,308.7188
| null | 36.666657
|
white
| 20.699219
| 28
| 0.562988
| 0.494995
| 4
| 0
| 0
|
no
| 0.3
| 0.3
|
no dnr
| 20
| 120
| 25
| 95
| 37
| 38.69531
| 192.5
| null | null | 1
| 141
| 7.429688
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 20
| 1
|
68.50696
|
female
| 1
| 40
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| null | null | 41
| 195,778.25
| 126,928.938
| null | 41
|
white
| 25.699219
| 28
| 0.55188
| 0.438965
| 6
| 0
| 0
|
no
| null | null |
dnr after sadm
| 31
| 107
| 28.296875
| 100
| 36
| 36.09375
| 250
| 3.199707
| 1.299805
| 0.699951
| 131
| 7.439453
| null | null | null | null | null |
<2 mo. follow-up
| 2.275391
| 40
| 1
|
36.16199
|
female
| 0
| 47
|
Coma
|
Coma
| 0
| 12
| null | 100
| 120,483.062
| 79,610
| null | 35.75
|
white
| 22.597656
| 25
| 0.53894
| 0.469971
| 1
| 0
| 0
|
no
| 0.5
| 0.5
|
no dnr
| 47
| 77
| 18.796875
| 110
| 25
| 36.19531
| 277.125
| 3.599609
| 1.299805
| 0.899902
| 137
| 7.489258
| null | null | null | null | 0
|
adl>=4 (>=5 if sur)
| 0
| 1,963
| 0
|
49.12299
|
male
| 0
| 23
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 12
|
$25-$50k
| 0
| 32,006.594
| 22,374.8281
| null | 26.666656
|
white
| 25.898438
| 23
| 0.844971
| 0.744995
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 23
| 63
| 6.699219
| 74
| 24
| 36.79688
| null | null | 2.5
| 1.299805
| 118
| null | null | null | null | 1
| 0
| null | 0
| 141
| 1
|
24.049
|
male
| 0
| 22
|
CHF
|
COPD/CHF/Cirrhosis
| 4
| 14
|
under $11k
| 0
| null | null | null | 18.666656
|
black
| 28.597656
| 40
| 0.870972
| 0.785889
| 3
| 0
| 0
|
no
| null | null |
no dnr
| 22
| 88
| 30
| 112
| 36
| 38
| 322.8125
| null | 9.798828
| 1.199951
| 136
| 7.449219
| null | null | null | null | 6
|
<2 mo. follow-up
| 6
| 29
| 1
|
30.76799
|
male
| 0
| 17
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
| null | 0
| 20,983.391
| 15,626
| null | 11
|
black
| 26.898438
| 37
| 0.859985
| 0.81189
| 2
| 0
| 0
|
no
| 0.8
| 0.75
|
no dnr
| 17
| 67
| 12.199219
| 80
| 30
| 39.29688
| 276.1875
| 2.399902
| 7.099609
| 0.599976
| 131
| 7.489258
| null | null | null | 1
| 0
|
no(M2 and SIP pres)
| 0
| 71
| 1
|
76.40497
|
female
| 1
| 19
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 12
| null | 9
| 130,559.938
| 87,684.9375
| null | 46.333313
|
white
| 19.097656
| 37
| 0.687988
| 0.594971
| 29
| 0
| 0
|
yes
| null | null |
dnr after sadm
| 12
| 58
| 13.298828
| 68
| 25
| 39.29688
| 316.625
| 2.099609
| null | 0.899902
| 135
| 7.449219
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 19
| 1
|
46.53
|
male
| 1
| 6
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 11
| null | 0
| 21,262.891
| 15,565.0938
| null | 41
|
white
| 32.195313
| 63
| 0.747925
| 0.667969
| 1
| 0
| 0
|
no
| null | null |
dnr after sadm
| 6
| 61
| 15
| 122
| 8
| 37.29688
| 196
| 3
| 3.899902
| 2.399902
| 135
| 7.269531
| null | null | null | null | 1
|
<2 mo. follow-up
| 1
| 6
| 1
|
44.60498
|
male
| 0
| 31
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 4
| null | null | 26
| 148,688
| 103,548.562
| null | 21.25
|
black
| 29.699219
| 51
| 0.616943
| 0.511963
| 31
| 0
| 0
|
no
| 0.9
| 0.8
|
no dnr
| 31
| 133
| 9.599609
| 90
| 22
| 37.5
| 440
| 2.599609
| 23.699219
| 2.799805
| 136
| 7.329102
| null | null | null | null | 7
|
no(M2 and SIP pres)
| 7
| 1,957
| 0
|
71.69098
|
male
| 1
| 4
|
Coma
|
Coma
| 2
| null | null | 100
| 12,116.844
| 8,462.4375
| null | 36
|
white
| 30.898438
| 73
| 0.035995
| 0.016998
| 1
| 0
| 0
|
no
| 0
| 0
|
dnr after sadm
| 2
| 55
| 10.5
| 152
| 50
| 38
| 282.8125
| null | 0.5
| 7.5
| 138
| 7.219727
| null | null | null | null | null |
<2 mo. follow-up
| 2.905273
| 4
| 1
|
64.94995
|
female
| 0
| 36
|
MOSF w/Malig
|
ARF/MOSF
| 2
| null | null | 37
| 62,986.688
| 43,444.7188
| null | 26.5
|
black
| 28.898438
| 59
| 0.265991
| 0.159973
| 3
| 0
| 0
|
metastatic
| null | null |
no dnr
| 36
| 52
| 24.699219
| 180
| 7
| 38
| 260
| 2.5
| 2.399902
| 1.699951
| 141
| 7.529297
| null | null | null | null | null |
<2 mo. follow-up
| 3.849609
| 48
| 1
|
46.85797
|
male
| 1
| 11
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 6
|
under $11k
| 55
| 73,627.125
| 50,169.4062
| null | 40.5
|
white
| 36.59375
| 78
| 0.313965
| 0.199982
| 6
| 0
| 0
|
no
| 0.3
| 0.2
|
dnr after sadm
| 9
| 68
| 28.699219
| 100
| 29
| 38.09375
| 186
| 2.899902
| 24.5
| 6.299805
| 144
| 7.399414
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 11
| 1
|
67.70197
|
male
| 0
| 8
|
Lung Cancer
|
Cancer
| 1
| null | null | 0
| 7,427.547
| 5,059.1406
| null | 13.5
|
white
| 20.097656
| 28
| 0.634888
| 0.324951
| 1
| 0
| 0
|
metastatic
| 0.1
| 0.001
|
dnr after sadm
| 2
| 83
| 12.599609
| 100
| 36
| 36.19531
| 308
| null | 0.299988
| 1.099854
| 143
| 7.459961
| null | null | null | null | null |
<2 mo. follow-up
| 2.849121
| 39
| 1
|
38.883
|
male
| 1
| 12
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| null | null | 9
| 25,195.344
| 16,901.6562
| null | 30
|
black
| 30.398438
| 34
| 0.780884
| 0.709961
| 1
| 0
| 0
|
no
| 0.85
| 0.75
|
dnr after sadm
| 10
| 70
| 11
| 98
| 9
| 34.59375
| 384
| null | 3.599609
| 0.399963
| 142
| 7.489258
| null | null | null | null | 3
|
<2 mo. follow-up
| 3
| 12
| 1
|
76.06799
|
male
| 0
| 5
|
Lung Cancer
|
Cancer
| 1
| null | null | 0
| 3,971.6
| 3,286.3984
| null | 5
|
white
| 14.298828
| 23
| 0.734985
| 0.465942
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 5
| 74
| 7.599609
| 88
| 24
| 36.59375
| 480.9375
| null | null | 1.099854
| 142
| 7.5
| null | null | null | null | null | null | 2.061035
| 70
| 1
|
65.52197
|
male
| 0
| 7
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 2
| 16
|
$25-$50k
| 0
| 5,249.898
| 3,816.7031
| null | 9.5
|
black
| 16.199219
| 20
| 0.719971
| 0.563965
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 7
| 87
| 3.099609
| 84
| 20
| 36.5
| null | 2.399902
| 2.599609
| 0.799927
| 137
| null | null | null | null | 0
| 1
|
adl>=4 (>=5 if sur)
| 1
| 80
| 1
|
62.366
|
female
| 0
| 4
|
Colon Cancer
|
Cancer
| 1
| 16
|
$25-$50k
| 0
| 2,857.299
| 2,059.7793
| null | 10
|
white
| 41.398438
| 50
| 0.241974
| 0.029999
| 1
| 0
| 0
|
metastatic
| 0.1
| 0.001
|
no dnr
| 4
| 78
| 13
| 110
| 36
| 36
| null | 2.299805
| 4
| 1
| 131
| null | null | null | null | 0
| 0
|
<2 mo. follow-up
| 0
| 14
| 1
|
57.64798
|
female
| 0
| 21
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 12
|
$25-$50k
| 0
| 45,167.531
| 31,629.2344
| null | 27
|
white
| 21.097656
| 38
| 0.807983
| 0.743896
| 3
| 1
| 0
|
yes
| null | null |
no dnr
| 21
| 78
| 11
| 112
| 40
| 38.5
| 290
| null | null | 1.099854
| 138
| 7.519531
| null | null | null | 3
| 0
| null | 0
| 322
| 1
|
56.60498
|
female
| 0
| 3
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| null | null | 0
| 4,187.199
| 2,915.0039
| null | 4
|
white
| 15.398438
| 14
| 0.918945
| 0.861938
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 3
| 67
| 6.899414
| 68
| 20
| 36
| null | null | 0.599976
| 1.199951
| 139
| null | null | null | null | null | null | null | 1.932617
| 1,952
| 0
|
63.04199
|
male
| 0
| 236
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 16
|
$25-$50k
| 0
| 504,659.5
| 338,955
| null | 46
|
white
| 19.898438
| 34
| 0.844971
| 0.791992
| 3
| 0
| 0
|
no
| 0.75
| 0.7
|
dnr after sadm
| 148
| 72
| 18.199219
| 120
| 10
| 37.79688
| 267.5
| 1.799805
| 0.399963
| 1.399902
| 137
| 7.389648
| null | null | null | null | 0
|
adl>=4 (>=5 if sur)
| 0
| 1,441
| 1
|
21.13599
|
male
| 0
| 32
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
|
$11-$25k
| 0
| 163,675.25
| 110,659.25
| null | 29.25
|
white
| 27.296875
| 41
| 0.843994
| 0.790894
| 20
| 0
| 0
|
no
| null | null |
no dnr
| 32
| 143
| 16.296875
| 68
| 8
| 35.09375
| 260
| 2.5
| 9.798828
| 0.899902
| 147
| 7.509766
| null | null | null | null | 0
|
adl>=4 (>=5 if sur)
| 0
| 275
| 1
|
58.32199
|
female
| 0
| 7
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 12
|
under $11k
| 0
| 15,772.445
| 11,455.75
| null | 19.5
|
white
| 25.398438
| 36
| 0.835938
| 0.731934
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 7
| 90
| 13.599609
| 110
| 20
| 37.19531
| 148
| null | null | 0.599976
| 138
| 7.459961
| null | null | null | 4
| 0
|
no(M2 and SIP pres)
| 0
| 877
| 1
|
44.97998
|
female
| 0
| 15
|
Colon Cancer
|
Cancer
| 1
| null | null | 0
| 14,023.094
| 10,758.6016
| null | 12.333328
|
white
| 12.398438
| 17
| 0.894897
| 0.758911
| 1
| 0
| 0
|
metastatic
| 0.9
| 0.75
|
no dnr
| 15
| 97
| 7.199219
| 72
| 16
| 36.79688
| null | 4.099609
| 5.299805
| 0.699951
| 139
| null | null | null | null | null | null | null | 2.092773
| 674
| 1
|
53.43997
|
male
| 0
| 53
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 14
|
$25-$50k
| 55
| 88,128.812
| 63,449.3438
| null | 32.5
|
white
| 33.59375
| 60
| 0.438965
| 0.31897
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 53
| 65
| 16.699219
| 125
| 31
| 38.19531
| 152
| 3.399902
| 2.699707
| 7.399414
| 133
| 7.369141
| null | null | null | null | 6
|
no(M2 and SIP pres)
| 6
| 1,950
| 0
|
65.17999
|
male
| 0
| 52
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 5
|
under $11k
| 0
| 96,142.25
| 65,433.5938
| null | 25.75
|
white
| 17.199219
| 22
| 0.883911
| 0.841919
| 1
| 0
| 0
|
no
| 0.95
| 0.94
|
no dnr
| 52
| 112
| 15.398438
| 85
| 15
| 37.19531
| 266.625
| 1.699951
| 0.599976
| 0.899902
| 131
| 7.469727
| null | null | null | 4
| null | null | 3.183199
| 103
| 1
|
70.69397
|
male
| 0
| 18
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 11
|
under $11k
| 9
| 22,192.984
| 16,123.9609
| null | 18
|
white
| 25.199219
| 31
| 0.7229
| 0.637939
| 2
| 0
| 0
|
no
| null | null |
no dnr
| 18
| 74
| 12
| 90
| 19
| 35.5
| 316
| 2.599609
| 5.799805
| 0.899902
| 133
| 7.349609
| null | null | null | 1
| 0
|
no(M2 and SIP pres)
| 0
| 865
| 1
|
62.806
|
male
| 0
| 5
|
Lung Cancer
|
Cancer
| 2
| 10
|
$25-$50k
| 0
| 6,054.199
| 3,734.2539
| null | 10
|
white
| 11.099609
| 25
| 0.810913
| 0.593994
| 1
| 0
| 0
|
metastatic
| 0.9
| 0.5
|
no dnr
| 5
| 135
| 15.099609
| 92
| 20
| 36.79688
| null | 4.099609
| 0.5
| 1.5
| 135
| null | null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 362
| 1
|
45.38498
|
female
| 1
| 10
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| null | null | 0
| 49,908.031
| 33,091.8125
| null | 50
|
black
| 26.898438
| 16
| 0.665894
| 0.56897
| 12
| 0
| 0
|
metastatic
| 0.1
| 0.001
|
dnr after sadm
| 8
| 80
| 5.899414
| 115
| 26
| 36.09375
| 282.8125
| null | null | 0.699951
| 130
| 7.339844
| null | null | null | null | null |
<2 mo. follow-up
| 2.750488
| 10
| 1
|
44.13998
|
male
| 0
| 84
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
|
$25-$50k
| 0
| 148,803.75
| 101,513.938
| null | 26.25
|
black
| 24.296875
| 26
| 0.853882
| 0.802979
| 2
| 0
| 0
|
no
| 0.95
| 0.95
|
no dnr
| 84
| 123
| 11.298828
| 115
| 38
| 37.59375
| 175.5
| 2.799805
| 0.899902
| 1
| 142
| 7.399414
| null | null | null | null | 0
| null | 0
| 1,947
| 0
|
76.33099
|
female
| 1
| 24
|
Coma
|
Coma
| 0
| null | null | 100
| null | null | null | 21.333328
|
black
| 14.798828
| 19
| 0.355957
| 0.282959
| 1
| 0
| 0
|
no
| 0.01
| 0.000001
|
dnr after sadm
| 5
| 125
| 15
| 85
| 22
| 37.29688
| 243.3125
| null | null | 1.099854
| 141
| 7.439453
| null | null | null | null | 2
|
<2 mo. follow-up
| 2
| 24
| 1
|
77.11694
|
male
| 1
| 21
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 11
|
under $11k
| 37
| null | null | null | 38
|
white
| 30.398438
| 50
| 0.279968
| 0.17099
| 8
| 0
| 0
|
yes
| 0.4
| 0.1
|
no dnr
| 21
| 55
| 17.898438
| 110
| 14
| 36
| 140
| 1.599854
| 0.399963
| 1.099854
| 151
| 7.389648
| null | null | null | null | 7
|
<2 mo. follow-up
| 7
| 21
| 1
|
53.11697
|
male
| 1
| 17
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 6
|
under $11k
| 9
| 36,496.094
| 25,353.0469
| null | 28.666656
|
black
| 41.296875
| 51
| 0.453979
| 0.333984
| 1
| 0
| 0
|
no
| null | null |
dnr after sadm
| 13
| 72
| 24.296875
| 98
| 24
| 35.39844
| 344.4375
| 2.5
| 50.195313
| 2.099609
| 134
| 7.40918
| null | null | null | null | 4
|
<2 mo. follow-up
| 4
| 17
| 1
|
50.64999
|
male
| 0
| 38
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 14
|
$25-$50k
| 0
| null | null | null | 13.75
|
white
| 12
| 7
| 0.935913
| 0.911987
| 2
| 0
| 0
|
no
| 0.9
| 0.85
|
no dnr
| 38
| 82
| 8.398438
| 70
| 16
| 37.29688
| 466.625
| null | 0.399963
| 1.099854
| 141
| 7.379883
| null | null | null | 1
| 0
|
no(M2 and SIP pres)
| 0
| 1,945
| 0
|
72.47894
|
male
| 1
| 4
|
Lung Cancer
|
Cancer
| 1
| null | null | 100
| null | null | null | 21
|
white
| 49.398438
| 58
| 0
| 0
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 4
| 43
| 12.298828
| 0
| 0
| 36.59375
| 108.32812
| null | 0.799927
| 0.899902
| 133
| 7.179688
| null | null | null | null | null |
<2 mo. follow-up
| 3.746094
| 4
| 1
|
66.90997
|
female
| 1
| 19
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 10
|
$11-$25k
| 9
| null | null | null | 44
|
other
| 21.898438
| 37
| 0.770996
| 0.697998
| 5
| 1
| 0
|
no
| 0.8
| 0.512
|
dnr after sadm
| 17
| 72
| 11.5
| 120
| 40
| 38.09375
| 271.375
| null | null | 1.099854
| 138
| 7.449219
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 19
| 1
|
58.42798
|
female
| 1
| 6
|
MOSF w/Malig
|
ARF/MOSF
| 1
| null | null | 0
| 81,086.875
| 55,463.9688
| null | 44
|
white
| 26.5
| 35
| 0.455994
| 0.336975
| 35
| 0
| 0
|
metastatic
| 0.75
| 0.3
|
dnr before sadm
| -8
| 67
| 18
| 135
| 10
| 38
| 276.625
| 2.699707
| 1
| 2.899902
| 145
| 7.40918
| null | null | null | null | null |
<2 mo. follow-up
| 2.383301
| 6
| 1
|
53.09497
|
male
| 0
| 32
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 14
| null | 55
| 57,829.438
| 41,323.5312
| null | 24.5
|
white
| 18.699219
| 20
| 0.768921
| 0.694946
| 2
| 0
| 0
|
no
| null | null |
no dnr
| 32
| 100
| 15.199219
| 70
| 28
| 37.59375
| 212
| null | 0.699951
| 0.699951
| 136
| 7.40918
| null | null | null | null | 0
|
adl>=4 (>=5 if sur)
| 0
| 1,946
| 0
|
42.95697
|
male
| 0
| 22
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
|
$11-$25k
| 0
| 45,774.219
| 32,444.4531
| null | 36
|
white
| 38.695313
| 65
| 0.630981
| 0.527954
| 1
| 0
| 0
|
no
| 0.8
| 0.9
|
no dnr
| 22
| 67
| 28.5
| 125
| 24
| 38.69531
| 59
| 1.299805
| 1.599854
| 4.5
| 149
| 7.429688
| null | null | null | null | 2
|
adl>=4 (>=5 if sur)
| 2
| 1,945
| 0
|
61.38797
|
female
| 0
| 7
|
Lung Cancer
|
Cancer
| 1
| 16
|
>$50k
| 0
| 7,101.348
| 5,534.457
| null | 4
|
white
| 15.798828
| 9
| 0.738892
| 0.472961
| 1
| 0
| 0
|
metastatic
| 0.3
| 0.05
|
no dnr
| 7
| 94
| 7
| 86
| 18
| 36.19531
| null | null | null | 0.899902
| 135
| null | null | null | null | 1
| 6
|
adl>=4 (>=5 if sur)
| 6
| 81
| 1
|
30.63699
|
female
| 1
| 5
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| null | null | 0
| 24,373.297
| 17,057.125
| null | 58
|
black
| 42.09375
| 70
| 0.596924
| 0.488953
| 2
| 0
| 0
|
no
| null | null |
no dnr
| 5
| 131
| 16.097656
| 220
| 36
| 35.5
| 465
| null | 32.59375
| 1.699951
| 151
| 7.509766
| null | null | null | null | null |
<2 mo. follow-up
| 1.937256
| 5
| 1
|
51.77298
|
male
| 0
| 23
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 12
|
$25-$50k
| 0
| 71,611.188
| 49,917.3438
| null | 31.333328
|
white
| 41.59375
| 69
| 0.136993
| 0.063995
| 23
| 0
| 0
|
yes
| 0.5
| 0.5
|
no dnr
| 23
| 54
| 0.099991
| 90
| 36
| 39.09375
| 115
| null | 1.099854
| 2.5
| 136
| 7.389648
| null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 236
| 1
|
80.41595
|
female
| 0
| 14
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 13
|
under $11k
| 0
| 19,865.688
| 14,454.7734
| null | 20.333328
|
white
| 32.09375
| 55
| 0.430969
| 0.311951
| 4
| 0
| 0
|
yes
| 0.6
| 0.5
|
no dnr
| 14
| 112
| 18.296875
| 140
| 37
| 35.19531
| 142.84375
| 2.199707
| 0.399963
| 1.299805
| 136
| 7.489258
| null | null | null | 0
| 1
|
no(M2 and SIP pres)
| 1
| 1,940
| 0
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.